Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.7K Buy
170
+85
+100% +$9.62K ﹤0.01% 6086
2026
Q1
$9.46K Sell
85
-20
-19% -$2.37K ﹤0.01% 6328
2025
Q4
$14.2K Buy
105
+68
+184% +$7.42K ﹤0.01% 6105
2025
Q3
$3.08K Buy
+37
New +$2.27K ﹤0.01% 6988
2025
Q1
Sell
-25
Closed -$183 7422
2024
Q4
$183 Sell
25
-7
-22% -$64 ﹤0.01% 7177
2024
Q3
$369 Buy
32
+26
+433% +$312 ﹤0.01% 7066
2024
Q2
$79 Buy
+6
New +$86 ﹤0.01% 7269

Other funds holding ABVX

Osaic Holdings's ABVX Position: Q2 2026 in Review

Osaic Holdings increased its Abivax (ABVX) stake by 100% in Q2 2026, buying an estimated $9.62K and bringing the position to 170 shares worth $22.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6086.

Osaic Holdings first reported a position in ABVX in Q2 2024 and has held it in 7 quarters since. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Osaic Holdings held 170 shares of Abivax worth $22.7K as of Q2 2026.
  • Osaic Holdings bought 85 Abivax shares in Q2 2026, an estimated $9.62K.
  • Abivax made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6086 holding.
  • Osaic Holdings first reported a position in Abivax in Q2 2024 and has held it in 7 quarters since.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.